Belite Bio, Inc (BLTE)

NCM – Real Time Price. Currency in USD

176.96

-0.62 (-0.35%)

Market open: Aug 12, 2026, 2:23 PM EDT

181.56

+3.98 (2.24%)

Previous after-hours: Aug 11, 2026, 7:50 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

Cost of goods sold

-464K

-449K

-399K

-198K

Gross Profit

-464K

-449K

-399K

-198K

Operating expenses (excl. COGS)

-84M

-40M

-31M

-13M

Operating Income

-84M

-40M

-32M

-13M

Non-operating income, total

45K

173K

Pretax income

-78M

-36M

-32M

-13M

Equity in earnings

Taxes

-6K

-9K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-78M

-36M

-32M

-13M

Discontinued operations

Net income

-78M

-36M

-32M

-13M

Dilution adjustment

Preferred dividends

Belite Bio, Inc (BLTE)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Belite Bio, Inc (BLTE)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Belite Bio, Inc (BLTE)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Belite Bio, Inc (BLTE)

Income Statement (Annual)

Income Statement (Annual)